Product information and disease descriptionProduct descriptionProduct information
Indication
1 evidence topic · 1 source
Investigational indication
| Type of information | Source quotation |
|---|---|
| Disease or anticipated indication | “Essential Tremor” |
Ulixacaltamide
Essential tremor
- Manufacturer
- Praxis Precision Medicines
- Regulatory submission
- NDA submitted by February 2026
- Launch
- Not announced
- Last updated